Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.8750 (-6.25%) ($7.8750 - $7.8750) on Thu. Nov. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.34% (three month average) | RSI | 71 | Latest Price | $7.8750(-6.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 2.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 15.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(81%) XBI(80%) ARKK(70%) IBUY(68%) IBB(67%) | Factors Impacting EDIT price | EDIT will decline at least -2.17% in a week (0% probabilities). TBT(-25%) VXX(-16%) UUP(-12%) VIXM(-1%) USO(5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.17% (StdDev 4.34%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.4(-6.25%) | 10 Day Moving Average | $7.57(4.03%) | 20 Day Moving Average | $7.11(10.76%) | To recent high | -13.7% | To recent low | 25.8% | Market Cap | $489m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |